E-ISSN 2146-8346


Journal of Behavioral Health. 2012; 1(1):(8-295)


Role of piracetam in treatment of cerebral palsy disease

Marwa O. Elgendy, Sadia A. Tayel, Mohamed E.A. Abdelrahim, Ahmed M.A. Ali, Mohamed H. Meabed

Abstract

The term cerebral palsy (CP) refers to neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. Piracetam is a compound chemically related to gamma-aminobutyric acid (GABA). It crosses the blood-brain barrier but does not produce any overt central or autonomic nervous system effects. The aim of this prospective study was to evaluate and compare the effect of different doses of Piracetam on clinical status and intellectual power of cerebral palsy patient. The study was carried out on 40 cerebral palsy patients; 22 out of them were females, aged from 1 to 4.75 years old; from outpatient clinic at Beni Suef University Hospital. Patients were divided into four equal groups. Group A received dose 40mg/kg/day, group B received dose 80mg/kg/day, group C received dose 120mg/kg/day and group D was the control group, did not receive any Piracetam. Patients were treated and followed up for 6 month. They were represented by full history taking and clinical examination. The Intelligence quotient (IQ) test was done for every patient to evaluate mental development before starting piracetam treatment and every month for six months. There was an improvement in general health of children after therapy and quotient. Dose 120mg/kg/day of piracetam was found to be the most effective dose piracetam in the treatment of cerebral palsy disease as shown by improved scores of IQ test. The best improvement in mental and motor development was greatly observed in group C. Dose 40mg/kg/day of piracetam showed insignificant effect on improving the IQ of the patients

Most Viewed Article
  • Defining the personal determinants of health for older adults
    Stephanie MacLeod, Sandra Kraemer, Rifky Tkatch, Annette Fellows, Laurie Albright, Michael McGinn, James Schaeffer and Charlotte S. Yeh
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Habitat Divide in the Practice of Cleanliness as Disease Prevention Measure
    Dr Hamilton-Ekeke Joy-Telu, Dr Odibo Anthony Ajakpovi, Blessing C. Cleopas, Mercy Telu
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Test Period Stress: Factor on Eating and Physical Activity in College of Nayarit Mexico
    José Enrique Jiménez-Hernández and Gilberto Mercado-Mercado
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Does the Prevailing Awareness Reflect on Hygiene Practices for Handling Fish in Zanzibar?
    Zakia M. Abubakar, Rabia, A.R, Ali M. Ussi and Asma, A. Hamad
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Occupational Therapy Assessment and Intervention of a 22 Month Old Girl with Feeding Refusal
    Berta Gándara-Gafo, Tania Moriyón-Iglesias and Isabelle Beaudry-Bellefeuille
    » Abstract » doi: 10.5455/jbh.XXXXXX

Most Downloaded
  • Defining the personal determinants of health for older adults
    Stephanie MacLeod, Sandra Kraemer, Rifky Tkatch, Annette Fellows, Laurie Albright, Michael McGinn, James Schaeffer and Charlotte S. Yeh
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Habitat Divide in the Practice of Cleanliness as Disease Prevention Measure
    Dr Hamilton-Ekeke Joy-Telu, Dr Odibo Anthony Ajakpovi, Blessing C. Cleopas, Mercy Telu
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Test Period Stress: Factor on Eating and Physical Activity in College of Nayarit Mexico
    José Enrique Jiménez-Hernández and Gilberto Mercado-Mercado
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Does the Prevailing Awareness Reflect on Hygiene Practices for Handling Fish in Zanzibar?
    Zakia M. Abubakar, Rabia, A.R, Ali M. Ussi and Asma, A. Hamad
    » Abstract » doi: 10.5455/jbh.XXXXXX

  • Occupational Therapy Assessment and Intervention of a 22 Month Old Girl with Feeding Refusal
    Berta Gándara-Gafo, Tania Moriyón-Iglesias and Isabelle Beaudry-Bellefeuille
    » Abstract » doi: 10.5455/jbh.XXXXXX